fda warning letter compounding semaglutide october 2025 Compound versions of GLP-1 drugs for weight loss halted by Novo Nordisk protects US patients

+ Yes, PT-141 is well-tolerated when used as directed and may be used on-demand based on your needs and your providers recommendations

Among 86 million doses, there have been nine reports of vaccine-induced myocarditis deaths

Regulatory status: Retatrutide is not approved by the FDA, EMA, or any other regulatory body, and the FDA has explicitly stated it cannot be used in compounding under federal law [5][6]

Finally, consistent product quality and approval require scalable, reproducible manufacturing processes (e.g., microfluidic synthesis and rigorous physicochemical characterization), combined with early regulatory engagement [191]